In a cohort of 205 African American patients with biopsy-proven FSGS, Genovese et al. (172) showed that the APOL1 G1 haplotype was present in 52% of FSGS cases as opposed to 18% in controls. Here, APOL1 is linked to focal segmental glomerulosclerosis.